135 related articles for article (PubMed ID: 35020947)
21. Microcystic stromal tumor of the ovary: a recurrent case with somatic CTNNB1 missense mutation.
Kojima N; Yoshida H; Uno M; Hiranuma K; Naka T; Shiraishi K; Kato T
Virchows Arch; 2022 Nov; 481(5):799-804. PubMed ID: 35699785
[TBL] [Abstract][Full Text] [Related]
22. Uterine Tumor Resembling Ovarian Sex Cord Tumor (UTROSCT) Commonly Exhibits Positivity With Sex Cord Markers FOXL2 and SF-1 but Lacks FOXL2 and DICER1 Mutations.
Croce S; de Kock L; Boshari T; Hostein I; Velasco V; Foulkes WD; McCluggage WG
Int J Gynecol Pathol; 2016 Jul; 35(4):301-8. PubMed ID: 26598979
[TBL] [Abstract][Full Text] [Related]
23. Identification of the most sensitive and robust immunohistochemical markers in different categories of ovarian sex cord-stromal tumors.
Zhao C; Vinh TN; McManus K; Dabbs D; Barner R; Vang R
Am J Surg Pathol; 2009 Mar; 33(3):354-66. PubMed ID: 19033865
[TBL] [Abstract][Full Text] [Related]
24. β-catenin (CTNNB1) S33C mutation in ovarian microcystic stromal tumors.
Maeda D; Shibahara J; Sakuma T; Isobe M; Teshima S; Mori M; Oda K; Nakagawa S; Taketani Y; Ishikawa S; Fukayama M
Am J Surg Pathol; 2011 Oct; 35(10):1429-40. PubMed ID: 21881488
[TBL] [Abstract][Full Text] [Related]
25. Ovarian sex cord-stromal tumors in patients with probable or confirmed germline DICER1 mutations.
Oost EE; Charles A; Choong CS; Leung YC; Salfinger S; Sonnendecker H; Tan J; Townshend S; Witkowski L; Foulkes WD; Stewart CJ
Int J Gynecol Pathol; 2015 May; 34(3):266-74. PubMed ID: 25844550
[TBL] [Abstract][Full Text] [Related]
26. Microcystic Stromal Tumor of Testicle: First Case Report and Literature Review.
Zhu P; Duan Y; Ao Q; Wang G
Cancer Res Treat; 2018 Oct; 50(4):1452-1457. PubMed ID: 29169232
[TBL] [Abstract][Full Text] [Related]
27. Sex cord-stromal tumors of the ovary and testis: their similarities and differences with consideration of selected problems.
Young RH
Mod Pathol; 2005 Feb; 18 Suppl 2():S81-98. PubMed ID: 15502809
[TBL] [Abstract][Full Text] [Related]
28. FOXL2 is a sensitive and specific marker for sex cord-stromal tumors of the ovary.
Al-Agha OM; Huwait HF; Chow C; Yang W; Senz J; Kalloger SE; Huntsman DG; Young RH; Gilks CB
Am J Surg Pathol; 2011 Apr; 35(4):484-94. PubMed ID: 21378549
[TBL] [Abstract][Full Text] [Related]
29. Calretinin, a more sensitive but less specific marker than alpha-inhibin for ovarian sex cord-stromal neoplasms: an immunohistochemical study of 215 cases.
Movahedi-Lankarani S; Kurman RJ
Am J Surg Pathol; 2002 Nov; 26(11):1477-83. PubMed ID: 12409724
[TBL] [Abstract][Full Text] [Related]
30. Ovarian microcystic stromal tumor with significant bizarre nuclei: A case report.
He Y; Xu L; Feng M; Wang W
Medicine (Baltimore); 2020 Aug; 99(34):e21841. PubMed ID: 32846831
[TBL] [Abstract][Full Text] [Related]
31. An immunohistochemical and molecular analysis of problematic and unclassified ovarian sex cord-stromal tumors.
Stewart CJ; Alexiadis M; Crook ML; Fuller PJ
Hum Pathol; 2013 Dec; 44(12):2774-81. PubMed ID: 24134930
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemistry as a diagnostic aid in the evaluation of ovarian tumors.
McCluggage WG; Young RH
Semin Diagn Pathol; 2005 Feb; 22(1):3-32. PubMed ID: 16512597
[TBL] [Abstract][Full Text] [Related]
33. [Ovarian tumors with endocrine function].
Guo LN; Liu TH; Sun AJ; Zhou Q
Zhonghua Bing Li Xue Za Zhi; 2004 Jun; 33(3):217-20. PubMed ID: 15256111
[TBL] [Abstract][Full Text] [Related]
34. The role of beta-catenin mutation and SOX9 expression in sex cord-stromal tumours of the testis.
Bremmer F; Behnes CL; Schildhaus HU; Gaisa NT; Reis H; Jarry H; Radzun HJ; Stroebel P; Schweyer S
Virchows Arch; 2017 Apr; 470(4):421-428. PubMed ID: 28204871
[TBL] [Abstract][Full Text] [Related]
35. Practical roles for molecular diagnostic testing in ovarian adult granulosa cell tumour, Sertoli-Leydig cell tumour, microcystic stromal tumour and their mimics.
Rabban JT; Karnezis AN; Devine WP
Histopathology; 2020 Jan; 76(1):11-24. PubMed ID: 31846522
[TBL] [Abstract][Full Text] [Related]
36. Signet ring stromal cell tumor revisited and related signet ring cell lesions of the ovary.
Roth LM; Ramzy I
Hum Pathol; 2014 Mar; 45(3):636-42. PubMed ID: 24342431
[TBL] [Abstract][Full Text] [Related]
37. A Morphologic and Immunohistochemical Comparison of Nuclear β-Catenin Expressing Testicular Sertoli Cell Tumors and Pancreatic Solid Pseudopapillary Neoplasms Supporting Their Continued Separate Classification.
Kao CS; Ulbright TM
Am J Surg Pathol; 2020 Aug; 44(8):1082-1091. PubMed ID: 32604170
[TBL] [Abstract][Full Text] [Related]
38. CD56 is a sensitive and diagnostically useful immunohistochemical marker of ovarian sex cord-stromal tumors.
McCluggage WG; McKenna M; McBride HA
Int J Gynecol Pathol; 2007 Jul; 26(3):322-7. PubMed ID: 17581419
[TBL] [Abstract][Full Text] [Related]
39. Ovarian microcystic stromal tumor: A novel extracolonic tumor in familial adenomatous polyposis.
Lee SH; Koh YW; Roh HJ; Cha HJ; Kwon YS
Genes Chromosomes Cancer; 2015 Jun; 54(6):353-60. PubMed ID: 25820106
[TBL] [Abstract][Full Text] [Related]
40. A Constellation of Rare Gynecological Malignancies and Familial Adenomatous Polyposis Gastrointestinal Adenocarcinoma: A Case Report.
Gill SJ; Pirzada A; Power P; Neveu J
Int J Gynecol Pathol; 2022 Nov; 41(6):622-627. PubMed ID: 36302191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
